AvenCell Therapeutics announced that it raised $115 million in a Series B round. The company is developing CAR-T therapies ...

Currently, financial markets are experiencing a mix of optimism and caution as investors react to changing economic ...

Donanemab has been described as a game-changer for Alzheimer's, with research showing it slowed its progressions by 35 per ...

Production of Prozac, an antidepressant, would end globally at the end of this year, drugmaker Eli Lilly and Co said in a press release yesterday after announcing in August that the drug would soon be ...

U.K. regulators will reportedly recommend the NHS not cover Eli Lilly’s (LLY) donanemab for the treatment of early ...

Chairman of the Senate Committee on Health, Education, Labor, and Pensions (HELP), today joined President Joe Biden in Concord, New Hampshire at the New Hampshire Technical Institute for an event on ...

Eli Lilly & Co. closed $63.38 below its 52-week high ($972.53), which the company reached on August 22nd.

The most effective drug for Alzheimer’s will be blocked for use on the NHS on Wednesday. Regulators are expected to declare ...

Britain's National Health Service (NHS) will block Eli Lilly's Alzheimer's drug donanemab on Wednesday, deeming it too ...

Four senators want to know more about Pfizer and Eli Lilly’s partnerships with telehealth providers, and whether that may ...

The historic Zion Baptist Church will receive nearly a quarter of a million dollars to preserve its history and architecture.